All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

ROMA (Risk Of Malignancy Algorithm) Scholarly Peer-review Journal

 ROMA is at present a valuable analytic device for the preoperative separation of patients with a pelvic mass, uncovering an awesome affectability and explicitness. Further investigations are required, in any case, in a huge gathering of patients and with tests from various producers to decide the ideal cutoff focuses for the calculation. ROMA performs better than CA125 and HE4 in type II and propelled diseases. Ladies with ovarian malignancy manifestations and adnexal masses present basically to gynecologists, essential consideration doctors or general specialists. ROMA is a qualitative serum test that derives a numerical score from the results of CA-125 (the most widely accepted biomarker for ovarian cancer) and HE4 blood tests, plus menopausal status, to identify patients presenting with an adnexal mass as being at high or low likelihood for having malignancy

 

High Impact List of Articles

Relevant Topics in General Science

Select your language of interest to view the total content in your interested language

Table of Contents

Google Scholar citation report
Citations : 875

BioTechnology: An Indian Journal received 875 citations as per Google Scholar report

Indexed In

  • Google Scholar
  • Open J Gate
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Cosmos IF
  • Directory of Research Journal Indexing (DRJI)
  • Secret Search Engine Labs
  • Euro Pub

Read More

Recommended Conferences

26th World Congress on Biotechnology

Prague, Czech Republic

27th World Congress on Biotechnology

Prague, Czech Republic

27th Global Congress on Biotechnology

Paris, France

27th European Biotechnology Congress

Rome, Italy
Flyer
Global Tech Summit